CIK 0001048477
- Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680397820
- Phone
- +1 415-506-6700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,466,459
- in 2 filings
Net −$1,466,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-07 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −15,556 | $77.60 | $1.2M | 313,283 |
| 2021-05-07 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −6,115 | $78.77 | $482K | 307,168 |
| 2021-05-07 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −3,329 | $79.39 | $264K | 303,839 |
| 2021-05-07 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −25,000 | 8,513 | ||
| 2021-05-06 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +25,000 | $26.49 | $662K | 328,839 |
| 2021-05-06 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −14,825 | $78.01 | $1.2M | 314,014 |
| 2021-05-06 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −10,175 | $78.69 | $801K | 303,839 |
| 2021-05-06 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −25,000 | 33,513 | ||
| 2021-05-06 | MEIER RICHARD A Director | Exercise or conversion | +15,000 | $26.49 | $397K | 99,340 |
| 2021-05-06 | MEIER RICHARD A Director | Sale | −5,068 | $78.38 | $397K | 94,272 |
| 2021-05-06 | MEIER RICHARD A Director | Exercise or conversion · Stock Option (Right to buy Common Stock) | −15,000 | 0 | ||
| 2021-05-04 | Guyer Charles Greg EVP, Chief Technical Officer | Shares withheld for taxes | −3,986 | $78.35 | $312K | 41,695 |
| 2021-05-03 | Davis George Eric EVP, General Counsel | Sale | −2,584 | $78.30 | $202K | 66,197 |
| 2021-05-03 | Davis George Eric EVP, General Counsel | Sale | −2,089 | $78.30 | $164K | 64,108 |
| 2021-04-30 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Grant or award | +342 | $62.41 | $21K | 58,592 |
| 2021-04-30 | Acosta Andrea GVP, Chief Accounting Officer | Grant or award | +271 | $62.41 | $17K | 18,407 |
| 2021-04-30 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +341 | $62.41 | $21K | 31,357 |
| 2021-04-30 | BIENAIME JEAN JACQUES Chief Executive Officer | Grant or award | +341 | $62.41 | $21K | 303,839 |
| 2021-04-30 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award | +221 | $62.41 | $14K | 45,681 |
| 2021-04-30 | Davis George Eric EVP, General Counsel | Grant or award | +341 | $62.41 | $21K | 68,781 |
Page 29 of 36 · 707 trades